Kada Akiko, Nishimura Kunihiro, Nakagawara Jyoji, Ogasawara Kuniaki, Ono Junichi, Shiokawa Yoshiaki, Aruga Toru, Miyachi Shigeru, Nagata Izumi, Toyoda Kazunori, Matsuda Shinya, Suzuki Akifumi, Kataoka Hiroharu, Nakamura Fumiaki, Kamitani Satoru, Iihara Koji
Department of Clinical Trials and Research, Clinical Research Center, National Hospital Organization Nagoya Medical Center, 4-1-1 Sannomaru, Naka-ku, Nagoya, Aichi, 460-0001, Japan.
Center for Cardiovascular Disease Information, National Cerebral and Cardiovascular Center, Suita, Japan.
BMC Neurol. 2017 Feb 28;17(1):46. doi: 10.1186/s12883-017-0815-4.
Although the Brain Attack Coalition recommended establishing centers of comprehensive care for stroke and cerebrovascular disease patients, a scoring system for such centers was lacking. We created and validated a comprehensive stroke center (CSC) score, adapted to Japanese circumstances.
Of the selected 1369 certified training institutions in Japan, 749 completed an acute stroke care capabilities survey. Hospital performance was determined using a 25-item score, evaluating 5 subcategories: personnel, diagnostic techniques, specific expertise, infrastructure, and education. Consistency and validity were examined using correlation coefficients and factorial analysis.
The CSC score (median, 14; interquartile range, 11-18) varied according to hospital volume. The five subcategories showed moderate consistency (Cronbach's α = 0.765). A strong correlation existed between types of available personnel and specific expertise. Using the 2011 Japanese Diagnosis Procedure Combination database for patients hospitalized with stroke, four constructs were identified by factorial analysis (neurovascular surgery and intervention, vascular neurology, diagnostic neuroradiology, and neurocritical care and rehabilitation) that affected in-hospital mortality from ischemic stroke, intracerebral hemorrhage, and subarachnoid hemorrhage. The total CSC score was related to in-hospital mortality from ischemic stroke (odds ratio [OR], 0.973; 95% confidence interval [CI], 0.958-0.989), intracerebral hemorrhage (OR, 0.970; 95% CI, 0.950-0.990), and subarachnoid hemorrhage (OR, 0.951; 95% CI, 0.925-0.977), with varying contributions from the four constructs.
The CSC score is a valid measure for assessing CSC capabilities, based on the availability of neurovascular surgery and intervention, vascular neurology, diagnostic neuroradiology, and critical care and rehabilitation services.
尽管脑卒中介入联盟建议为中风和脑血管疾病患者建立综合护理中心,但缺乏针对此类中心的评分系统。我们创建并验证了一个适用于日本情况的综合卒中中心(CSC)评分。
在日本选定的1369家认证培训机构中,749家完成了急性卒中护理能力调查。使用25项评分来确定医院表现,评估5个亚类:人员、诊断技术、专业技能、基础设施和教育。使用相关系数和因子分析来检验一致性和有效性。
CSC评分(中位数为14;四分位间距为11 - 18)因医院规模而异。五个亚类显示出中等一致性(克朗巴赫α系数 = 0.765)。可用人员类型与专业技能之间存在强相关性。利用2011年日本诊断程序组合数据库中中风住院患者的数据,通过因子分析确定了四个结构(神经血管手术与介入、血管神经病学、诊断性神经放射学以及神经重症监护与康复),这些结构影响缺血性中风、脑出血和蛛网膜下腔出血的院内死亡率。CSC总评分与缺血性中风(优势比[OR],0.973;95%置信区间[CI],0.958 - 0.989)、脑出血(OR,0.970;95% CI,0.950 - 0.990)和蛛网膜下腔出血(OR,0.951;95% CI,0.925 - 0.977)的院内死亡率相关,四个结构的贡献各不相同。
基于神经血管手术与介入、血管神经病学、诊断性神经放射学以及重症监护与康复服务情况,CSC评分是评估CSC能力的有效指标。